Aspire Biopharma’s BUZZ BOMBTM Partners with EoS Fitness to Empower High-Performance Lifestyles for Millions of Members

ESTERO, FL / ACCESS Newswire / May 27, 2026 / Aspire Biopharma Holdings, Inc.'s (Nasdaq:ASBP) ("Aspire" or the ...

Foresee Pharmaceuticals Announces Completion of Casppian Phase 3 Study with Last Patient Last Visit and Confirms Topline Results: 94% of Patients Achieve LH Suppression with 6 ...

Foresee outlines plan for NDA submission to FDA and other global health authorities by late 2026 Plan for NDA Submission and Global Regulatory Filings The Casppian ...

Barfresh (BRFH) Q4 2025 Earnings Call Transcript

The seasonal composition of revenue is set to shift, with Arps Dairy’s counter-seasonal product mix expected to offset ...